会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 15. 发明授权
    • Devices and methods for occlusion of the uterine arteries
    • 用于闭塞子宫动脉的装置和方法
    • US07771357B2
    • 2010-08-10
    • US10459342
    • 2003-06-10
    • Fred BurbankMichael JonesPaul Lubock
    • Fred BurbankMichael JonesPaul Lubock
    • A61B8/00A61B5/05A61B17/08
    • A61B8/12A61B8/06A61B8/0833A61B17/12013A61B17/42A61B18/1485
    • Devices and methods are disclosed for treating a uterine disorder which receive its blood supply from a uterine artery. In particular, uterine fibroids are effectively treated by occluding the uterine arteries using trans-vaginal, trans-uterine, transrectal, or retroperitoneal approaches. The devices and methods are advantageous because the inventive procedures may be performed by a patient's gynecologist in the course of treatment, avoiding the need for referrals to specialist practitioners and for more radical treatments, such as hysterectomies. The methods include both temporary and permanent occlusion of the arteries. A cannula carries an imaging device and a member which will easily penetrate tissue, the member including a device which partially or completely, and temporarily or permanently, occludes a uterine artery.
    • 公开了用于治疗从子宫动脉接受其血液供应的子宫疾病的装置和方法。 特别地,子宫肌瘤通过使用经阴道,经子宫,经直肠或腹膜后方法闭塞子宫动脉来有效治疗。 所述装置和方法是有利的,因为本发明的方法可以由患者的妇科医生在治疗过程中进行,避免需要转诊给专科医师,以及进行诸如子宫切除术等更激进的治疗。 这些方法包括动脉的临时和永久闭塞。 套管携带成像装置和容易穿透组织的构件,该构件包括部分地或完全地暂时地或永久地阻塞子宫动脉的装置。
    • 18. 发明申请
    • Imageable biopsy site marker
    • 可成像的活检部位标记
    • US20060155190A1
    • 2006-07-13
    • US11366956
    • 2006-03-02
    • Fred BurbankPaul LubockMichael JonesNancy Forcier
    • Fred BurbankPaul LubockMichael JonesNancy Forcier
    • A61B6/00
    • A61B90/39A61B10/02A61B2017/00004A61B2090/3788A61B2090/3908A61B2090/3925A61B2090/3929A61B2090/3933A61B2090/395A61B2090/3975A61B2090/3987A61B2090/3995A61K49/006A61M37/0069
    • A biopsy site marker having at least one small marker body or pellet of bioresorbable material such as gelatin, collagen, polylactic acid, polyglycolic acid which has a radiopaque object, preferably with a non-biological configuration. The at least one bioresorbable body or pellet with a radiopaque object is deposited into the biopsy site, by an delivery device that includes an elongated tubular body with a piston slidable within the tubular body. One end of the tube is placed into the biopsy site. At least one but preferably several marker bodies or pellets are deposited sequentially into the biopsy site through the tube. At least the bioresorbable materials of the detectable markers remain present in sufficient quantity to permit detection and location of the biopsy site at a first time point (e.g., 2 weeks) after introduction but clear from the biopsy site or otherwise do not interfere with imaging of tissues adjacent the biopsy site at a second time point (e.g., 5-7 months) after introduction.
    • 活检部位标记物,其具有至少一个生物可再吸收材料的小标记体或颗粒,例如具有不透射线对象的明胶,胶原,聚乳酸,聚乙醇酸,优选具有非生物构型。 具有不透射线物体的至少一个生物可再吸收体或丸粒通过包括细长管状体的递送装置沉积到活检部位中,所述细长管状体具有可在管状体内滑动的活塞。 将管的一端放入活检部位。 至少一个但优选几个标记体或丸粒通过管子依次沉积到活检部位。 至少可检测标记的生物可吸收材料保持足够的量,以允许在引入之后的第一时间点(例如2周)检测和定位活检部位,但是从活组织检查部位清除,否则不干扰成像 导入后的第二时间点(如5-7个月)附近的组织组织。